VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $926,000 | -4.6% | 84,967 | -1.0% | 0.00% | 0.0% |
| Q1 2022 | $971,000 | -31.9% | 85,863 | -5.5% | 0.00% | 0.0% |
| Q4 2021 | $1,425,000 | +3.6% | 90,820 | +13.1% | 0.00% | 0.0% |
| Q3 2021 | $1,376,000 | -41.8% | 80,295 | -37.6% | 0.00% | -80.0% |
| Q1 2019 | $2,366,000 | -14.5% | 128,598 | +21.5% | 0.01% | -28.6% |
| Q4 2018 | $2,766,000 | +120.9% | 105,874 | +51.4% | 0.01% | +133.3% |
| Q3 2017 | $1,252,000 | +10.1% | 69,942 | +0.2% | 0.00% | 0.0% |
| Q2 2017 | $1,137,000 | – | 69,785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |